Search results
...Alternative Weight-loss Medications That Cost Nearly 90 Percent Less, What to Know: Price, How It...
WWD via Yahoo Finance· 3 days agoBoth brands began offering weight-loss programs in December, though they didn’t sell medications...
Ozempic quells kidney disease risk, study finds
Becker’s Hospital Review· 19 hours agoIn a yearslong trial of more than 3,500 participants, Novo Nordisk's Ozempic and Wegovy slowed the growth of chronic kidney disease and slashed the risk of heart attack, kidney failure, stroke ...
Hims & Hers to sell inexpensive Ozempic alternative
New York Daily News· 4 days agoOnline pharmaceutical brands Hims & Hers are introducing a weight-loss drug containing a compounded form of semaglutide, the active ingredient in...
Hims & Hers Selling GLP-1 Weight Loss Drugs Like Wegovy for 85% Less: What to Know
Healthline via AOL· 2 days agoTelehealth company Hims & Hers announced they will begin selling off-brand GLP-1 drugs similar to...
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 3 days agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...
Hims & Hers to sell inexpensive Ozempic alternative
NY Daily News via Yahoo Finance· 4 days agoOnline pharmaceutical brands Hims & Hers are introducing a weight-loss drug containing a compounded form of semaglutide, the active ingredient in...
Many people quit new weight-loss drugs because of costs, side effects
United Press International via Yahoo News· 19 hours agoThree months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients...
Hims & Hers rolls out weight-loss shots much cheaper than Ozempic, Wegovy
FOX Business· 3 days agoHealth platform Hims & Hers Health Inc. announced Monday that it's rolling out injectable...
Hims & Hers Is Selling Copycat Weight-Loss Drugs. Here’s How.
Barrons.com· 2 days agoA plan by Hims & Hers Health to sell legal copies of Novo Nordisk weight loss drug Wegovy is drawing...
Why Is Mangoceuticals (MGRX) Stock Up 130% Today?
InvestorPlace· 3 days agoMangoceuticals (NASDAQ:MGRX) stock climbed up a staggering 130% at one point today after the company announced that its new oral formulations of its ...
